Analysis shows that there is ongoing robust biomarker evidence of brain ( neuroglial ) injury in COVID-19 even months after discharge from hospital .
COVER STORY
Ongoing Brain Injury Caused by COVID-19 May Not Always Be Detected by Routine Tests
Analysis shows that there is ongoing robust biomarker evidence of brain ( neuroglial ) injury in COVID-19 even months after discharge from hospital .
3
A new study details that markers of brain injury are present in the blood many months after COVID-19 infection , despite inflammation blood tests being normal . The full paper , “ Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses ,” is available in Nature Communications .
Professor Benedict Michael , Principal Investigator and Director of the University of Liverpool ’ s Infection Neuroscience Laboratory and Honorary Consultant Neurologist , The Walton Center NHS
Foundation Trust said , “ During the COVID-19 pandemic it became apparent that neurological complications were occurring in a significant proportion of hospitalized patients and even in those with mild COVID-19 infection .”
“ While some neurological ‘ symptoms ’ were often mild ( headache and muscle aches [ myalgia ]), it became clear that more significant and potentially life-changing new neurological ‘ complications ’ were occurring , including encephalitis ( brain inflammation ), seizures , and stroke .”